[1]张金春,王朝霞,李志华.培哚普利联合氨氯地平对原发性高血压伴左心室肥厚的逆转作用及对患者血浆N末端B型利钠肽原水平的影响[J].陕西医学杂志,2025,54(1):109-113.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.022]
　ZHANG Jinchun,WANG Chaoxia,LI Zhihua.Reversal effect of perindopril combined with amlodipine on essential hypertension with left ventricular hypertrophy and effect on plasma N-terminal B-type natriuretic peptide level[J].,2025,54(1):109-113.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.022]
点击复制

培哚普利联合氨氯地平对原发性高血压伴左心室肥厚的逆转作用及对患者血浆N末端B型利钠肽原水平的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年1期
页码:
109-113
栏目:
药物与临床
出版日期:
2025-01-05

文章信息/Info

Title:
Reversal effect of perindopril combined with amlodipine on essential hypertension with left ventricular hypertrophy and effect on plasma N-terminal B-type natriuretic peptide level
作者:
张金春; 王朝霞; 李志华
(上海交通大学医学院附属新华医院崇明分院心血管内科,上海 202150)
Author(s):
ZHANG Jinchun; WANG Chaoxia; LI Zhihua
(Department of Cardiology,Chongming Branch,Xinhua Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 202150,China)
关键词:
培哚普利;  氨氯地平;  原发性高血压伴左心室肥厚;  血浆N末端B型利钠肽原水平;  逆转作用
Keywords:
Perindopril;  Amlodipine;  Essential hypertension with left ventricular hypertrophy;  Plasma N-terminal B-type natriuretic peptide level;  Reverse effect
分类号:
R 541.3
DOI:
DOI:10.3969/j.issn.1000-7377.2025.01.022
文献标志码:
A
摘要:
目的:探究培哚普利联合氨氯地平对原发性高血压伴左心室肥厚的逆转作用及对血浆N末端B型利钠肽原(NT-ProBNP)水平的影响。方法:选择原发性高血压伴左心室肥厚患者138例为研究对象,按随机数表法分为三组,均46例。对照组1予以氨氯地平治疗,对照组2予以培哚普利治疗,观察组采用培哚普利联合氨氯地平治疗。比较临床疗效、治疗前后血压情况、舒张末期左室内径(LVDd)、室间隔厚度(I与T)、左室后壁厚度(PWT)、左室重量指数(LVMI)及NT-ProBNP、同型半胱氨酸(Hcy)心钠肽(ANP)水平。结果:观察组总有效率为95.65%(44/46)高于对照组1[80.43%(37/46)]和对照组2[76.09%(35/46)](均P<0.05),对照组1和对照组2比较无统计学差异(P>0.05)。治疗前,三组收缩压、舒张压、I与T、PWT、LVMI及血清NT-ProBNP、Hcy、ANP水平比较,差异无统计学意义(均P>0.05),治疗后,观察组收缩压(127.87±13.66 与 136.46±15.73 与 135.00±15.98)、舒张压(81.07±5.58 与 83.98±7.16 与 85.57±7.22)、LVDd(46.48±2.24 与 48.37±3.62 与 48.30±3.57)、I与T(10.00±1.38 与 11.20±1.50 与 11.24±1.55)、PWT(10.52±1.35 与 12.24±1.40 与 12.37±1.39)、LVMI(124.57±10.80 与 145.13±10.27 与 144.93±10.34)、NT-ProBNP(64.53±15.63 与 75.23±18.46 与 78.15±18.54)、Hcy(8.93±2.68 与 15.48±4.66 与 14.88±4.62)、ANP(139.95±38.64 与 216.84±59.15 与 213.87±59.23)水平均较对照组1和对照组2下降(均P<0.05),对照组1和对照组2比较无统计学差异(P>0.05)。结论:培哚普利联合氨氯地平对原发性高血压伴左心室肥厚治疗效果较好,可有效降低血压、改善左室相关指标,并降低NT-Pro BNP水平。
Abstract:
Objective: To investigate the effect of perindopril combined with amlodipine on the reversal of essential hypertension with left ventricular hypertrophy and the plasma N-terminal B-type natriuretic peptide(NT-Pro BNP)level.Methods:A total of 138 patients with essential hypertension and left ventricular hypertrophy were selected as the study subjects and divided into three groups(46 cases)according to random number table method.Control group 1 was treated with amlodipine,control group 2 was treated with perindopril,observation group was treated with perindopril combined with amlodipine.The clinical efficacy,blood pressure before and after treatment,end-diastolic left ventricular diameter(LVDd),ventricular septal thickness(IvsT),left ventricular posterior wall thickness(PWT),left ventricular mass index(LVMI),NT-ProBNP,homocysteine(Hcy)cardiac natriuretic peptide(ANP)levels were compared.Result:The total effective rate of the observation group was 95.65%(44/46)higher than that of the control group1 [80.43%(37/46)] and control group 2[76.09%(35/46)](all P<0.05),there was no significant difference between control group 1 and control group 2(P >0.05).Before treatment,there were no significant differences in systolic blood pressure,diastolic blood pressure,I vs T,PWT,LVMI and serum NT-ProBNP,Hcy and ANP levels between the three groups(all P>0.05).After treatment,systolic blood pressure(127.87±13.66 vs 136.46±15.73 vs 135.00±15.98),diastolic blood pressure(81.07±5.58 vs 83.98±7.16 vs 85.57±7.22),LVDd(46.48±2.24 vs 48.37±3.62 vs 48.30±3.57),I vs T(10.00±1.38 vs 11.20±1.50 vs 11.24±1.55),PWT(10.52±1.35 vs 12.24±1.40 vs 12.37±1.39),LVMI(124.57±10.80 vs 145.13±10.27 vs 144.93±10.34),NT-ProBNP(64.53±15.63 vs 75.23±18.46 vs 78.15±18.54),Hcy(8.93±2.68 vs 15.48±4.66 vs 14.88±4.62)and ANP(139.95±38.64 vs 216.84±59.15 vs 213.87±59.23)were lower than those of control group 1 and control group 2(P<0.05),there was no significant difference between control group 1 and control group 2(P>0.05).Conclusion:Perindopril combined with amlodipine is effective in the treatment of essential hypertension with left ventricular hypertrophy,which can effectively reduce blood pressure,improve left ventricular related indexes,and reduce NT-Pro BNP level.

参考文献/References:

[1] 谢丽圣.复方七芍降压片对自发性高血压大鼠血压及左心室肥厚的影响[J].陕西中医,2022,43(9):1191-1195.
[2] 李颖,黄桢,张婷,等.眩晕3号方治疗原发性高血压左室肥厚35例[J].陕西中医,2017,38(9):1155-1156.
[3] ZHANG W,ZHANG J,JIN F,et al.Efficacy of felodipine and enalapril in the treatment of essential hypertension with coronary artery disease and the effect on levels of Salusin-β,Apelin,and PON1 gene expression in patients[J].Cellular and Molecular Biology(Noisy-le-Grand,France),2022,67(6):174-180.
[4] 尹絮,宋雨,吴东彬.厄贝沙坦联合苯磺酸氨氯地平对难治性高血压患者降压效果、动脉粥样硬化及负性情绪的影响[J].实用心脑肺血管病杂志,2023,31(5):112-115.
[5] 宫海滨,王雷,李春梅.马来酸左氨氯地平治疗腹型肥胖的高血压患者的疗效[J].心血管康复医学杂志,2022,31(2):184-187.
[6] 王学坤,云璐,董瑜,等.西尼地平与氨氯地平联合缬沙坦对老年原发性高血压伴左心室肥厚患者影响的对比研究[J].实用心脑肺血管病杂志,2018,26(10):66-69,77.
[7] 马宏恩,王鑫,季朝红,等.脑钠肽通过环磷酸鸟苷/蛋白激酶G信号通路对高血压降压效果及左心室肥厚逆转作用的机制研究[J].陕西医学杂志,2023,52(10):1308-1312,1318.
[8] ROVNO H D S.Editorial for “Impact of gender on left ventricular deformation in patients with essential hypertension assessed by cardiovascular magnetic resonance tissue tracking”[J].Journal of Magnetic Resonance Imaging,2021,53(6):1721-1722.
[9] 秦俊峰,田英娜,张慧丽.苯磺酸左旋氨氯地平联合拉贝洛尔妊娠期高血压疾病对患者血管弹性功能及母婴结局的影响[J].医学临床研究,2022,39(7):1095-1097.
[10] 王剑,李燕秋,唐刚.培哚普利叔丁胺片和盐酸贝那普利片对急性心肌梗死患者左心室重构的影响[J].成都医学院学报,2021,16(4):495-499.
[11] LEE H,CHO S M J,KIM D W,et al.On-Treatment blood pressure and cardiovascular outcomes in adults with hypertension and left ventricular hypertrophy[J].Journal of the American College of Cardiology,2021,78(15):1485-1495.
[12] FENG L,KHAN A H,JEHAN I,et al.Sex disparity in left ventricular hypertrophy in South Asians with hypertension:Influence of central obesity and high blood pressure[J].Journal of Human Hypertension,2023,37(4):327-329.
[13] 王美力,蔡海滨,李东升.培哚普利联合卡维地洛对老年充血性心力衰竭患者心功能及炎性指标的影响[J].岭南心血管病杂志,2021,27(1):67-71.
[14] BICER S U,AYLA T,SULTAN D,et al.The effect of acupressure on blood pressure level and pulse rate in individuals with essential hypertension a randomized controlled trial[J].Holistic Nursing Practice,2021,35(1):40-48.
[15] 张淑霞,梁焕,赵国强.培哚普利及氨氯地平联合治疗对原发性高血压患者自主神经功能及胰岛素抵抗和血清视黄醇结合蛋白4表达的影响[J].心肺血管病杂志,2019,38(1):18-21.
[16] 李志华,张洪磊,刘洪强,等.培哚普利联合左旋氨氯地平对高血压合并左心室肥厚患者的临床价值分析[J].医学研究杂志,2022,51(5):104-106,73.
[17] 王颖,马思蕊,何旭.替米沙坦联合培哚普利治疗心力衰竭疗效及对患者左心室射血分数的影响[J].陕西医学杂志,2019,48(8):1066-1069.
[18] 张海川.培哚普利联合氢氯噻嗪或氨氯地平治疗老年高血压降压效果分析[J].空军医学杂志,2020,36(1):75-78.
[19] 高雨洁,徐怡,廖深根,等.非缺血性扩张型心肌病患者NT-proBNP与心脏磁共振初始T1值的相关性[J].中国医学影像学杂志,2022,30(7):669-675.
[20] 赵玉琦.血清尿酸及NT-proBNP在评估老年原发性高血压患者左室肥厚中的意义[J].陕西医学杂志,2017,46(4):484-485,500.
[21] 刘亚东,马利军,杨延星.冠心病病人冠状动脉斑块性质与Lp-PLA2、Hcy和D-二聚体水平的相关性分析[J].中西医结合心脑血管病杂志,2020,18(7):1100-1102.
[22] 谭嘉莉,郑珊珊,陈露诗,等.高同型半胱氨酸血症患者血清HCY表达对超敏C反应蛋白、尿酸等生化指标含量的影响[J].中国实验诊断学,2022,26(2):211-214.
[23] 曾英,王苗,吴九涛.血清PⅢNP、ANP表达与慢性心力衰竭合并心律失常左室功能相关性分析[J].中国循证心血管医学杂志,2021,13(9):1128-1131.
[24] 刘婧星,李娜,张玉保,等.脑立清胶囊联合培哚普利吲达帕胺片治疗老年原发性高血压的疗效观察[J].药物评价研究,2021,44(4):814-818.
[25] 刘超,蒋建刚,卢鹏云.培哚普利氨氯地平片(Ⅲ)复方制剂治疗原发性高血压的临床效果、依从性及经济性分析[J].中国医院药学杂志,2020,40(24):2565-2569.

相似文献/References:

[1]王 颖,马思蕊,何 旭△.替米沙坦联合培哚普利治疗心力衰竭疗效及对患者左心室射血分数的影响[J].陕西医学杂志,2019,(8):1066.
　WANG Ying,MA Sirui,HE Xu..Efficacy of telmisartan combined with perindopril in the treatment of heart failure and its  effect on left ventricular ejection fraction in patients[J].,2019,(1):1066.

备注/Memo

备注/Memo:
基金项目:上海市卫生健康委员会科研项目(2020MY0296)
更新日期/Last Update: 2025-01-06